The company reported a year-on-year increase in revenue from operations and profit after tax, indicating strong performance across its segments, particularly in human and animal nutrition. The filing also outlines the company's operational performance and strategic outlook for the upcoming year, emphasizing ongoing product development and market expansion efforts.
Advanced Enzyme Technologies Limited has informed the Exchange regarding a press release dated August 02, 2025, titled "Pursuant to the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed is Press Release, titled "Quarterly Earnings Release dated August 02, 2025.".